URGENT: Protect your animals from the FDA’s dangerous plan!

The U.S. Food and Drug Administration(#FDA) is proposing regulatory guidance for compounded #animal medications that will likely cost you more — and even put your animals’ lives and health at risk.

Act Now: https://bit.ly/3aG6Og8

No, that’s not an exaggeration.

It’s called “Draft Guidance for Industry #256,” and it will make it harder and more expensive for #veterinarians to get the right medication for your #pets. We need your help to stop it.

#Veterinarians use compounded drugs because of the variety of dosage forms needed for so many varieties of animals. #Hamsters and #horses#alpacas, and #angoras … they all need very different dosages, and current #FDA-approved medications simply are not manufactured in the number of forms and dosages needed.

That’s why #pharmacy #compounding is so essential to animal health. When a pharmacy compounds a custom drug for your pet, they create the exact dose necessary, per the veterinarian’s order.

But GFI #256 will require that all animal #compounding begins with existing, #FDA-approved drugs, rather than with bulk ingredients (unless the #veterinarian documents that the compounded version is better and necessary). That means wasting time and adding frustration … but it also means your costs will likely go up.

#FDA-approved drugs are almost always more expensive than compounded medications made specifically for your pet from bulk ingredients by your pharmacist. Think of the price difference between a restaurant meal and one you cook at home. (It’s worse, actually. FDA-approved medications cost an average of three times as much as #compounded ones.)

#Vets might not have what they need on hand. Veterinarians keep some compounded medications in stock in their offices, too, but GFI #256 will limit those “office-use” drugs to a list of only certain compounded meds a vet is allowed to keep on hand for when immediate administration of the drug to an animal is necessary. That list will cover cities and suburbs, #farmland and ranches, #zoo animals and house pets, and will almost surely limit veterinarians’ options – and may put your pet at risk in the process.

Interestingly, the #FDA has no authorization from #Congress for this effort to regulate either #veterinary #medicine or animal compounding in this way.

That’s why a #bipartisan group in the House of Representatives — led by Donald Norcross (NJ), Mark Pocan (WI), and Ted Yoho (FL; he is also a veterinarian) — has written a letter asking FDA to withdraw GFI #256. They’re asking more members of #Congress to sign on.

We need you to urge your representative to sign the Norcross/Pocan/Yoho letter!

We’ve made it incredibly easy to send a message to your representative. We’ve even written a sample message to get you started! Just click the link below to send a message to #Congress and to the #FDA: Don’t put my #pets at risk!

And hurry, please. The comment period on the proposed regulatory guidance will be closing soon.

Key Compounding Pharmacy
We believe that only when people take charge of their health are they empowered to achieve a better quality of life.

© 2020 Key2Health Media.


Font Resize

Forgot Password?

Join Us

Password Reset
Please enter your e-mail address. You will receive a new password via e-mail.